Robert M. Murphy

Geen lopende functies

Health Technology

Profiel

ROBERT M.
MURPHY became a member of our board of directors on March 16, 2001, when we acquired ROBB PECK McCOOEY Financial Services, Inc., and has been the Chief Executive Officer of LaBranche & Co. LLC since March 16, 2001.
From 1985 to March 2001, Mr. Murphy was an Executive Vice President and director of ROBB PECK McCOOEY Financial Services, Inc. and served as Vice Chairman, President and Chief Executive Officer of ROBB PECK McCOOEY Specialist Corporation.
Mr. Murphy was a Vice-Chairman of the board of directors of the NYSE.
He also served on the NYSE's Market Performance Committee, Finance and Audit Committee, Committee for Review, Technology Planning and Oversight Committee and subcommittee on Floor Facilities.
Previously, he was a NYSE governor and floor official.

Eerdere bekende functies van Robert M. Murphy

Bedrijven	Functie	Einde
LAB International, Inc. LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies	President	13-07-2007

Ervaring van Robert M. Murphy in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit